4//SEC Filing
CAUWENBERGH GEERT 4
Accession 0001209191-18-045456
CIK 0001533040other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 9:29 PM ET
Size
7.7 KB
Accession
0001209191-18-045456
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Stock option (right to buy)
2018-08-01+21,000→ 21,000 totalExercise: $1.79Exp: 2028-08-01→ Common stock (21,000 underlying) - Award
Common Stock
2018-08-01+21,000→ 35,258 total
Holdings
- 450(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.
- [F2]The stock option will vest in four equal annual installments.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001285648
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 9:29 PM ET
- Size
- 7.7 KB